Navigation Links
Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits

ed in the morphine arm in the period 6 - 24 hours after treatment. This was the second primary endpoint and approached statistical significance (p=0.052).

Morphine formulations are the gold standard treatment for the relief of moderate to severe post-operative pain. A limitation of morphine treatment is often the unpleasant side effects experienced, of which nausea and vomiting are the most common. PONV is rated among patients as one of the most distressing after-effects of surgery and reduces their quality of life.

M6G's lower propensity to cause nausea and vomiting in the post-operative period strongly supports CeNeS' belief in the potential of M6G as a novel product for the treatment of post-operative pain with clear advantages over morphine.

3. Safety profile/adverse events

The trial confirmed that M6G's safety profile is similar to morphine. Aside from nausea and vomiting, the adverse events reported were at levels similar to those experienced by patients receiving morphine in a post-operative setting.

4. Management of PONV/use of anti-emetics

Secondary data revealed that patients receiving M6G required over 20% less anti-emetic medication over the 0-24 hour period than those in the morphine group. This shows that not only does M6G induce significantly less nausea and vomiting than morphine, but also that the post-operative anti-emetic treatment required is considerably reduced.

The potential for reduced anti-emetic drug costs combined with the reduction in medical assistance and the improved patient comfort due to lower PONV supports CeNeS' justification of a substantial price premium for M6G compared to morphine.

5. Drug consumption

It has been shown in previous studies that the dose of M6G required to provide analgesia immediately after surgery is three times that of morphine. In accordance with this, the M6G022 trial was designed such that M6G was available in a 3:1 ratio to morphine during the
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Molecular Target of Bradmers Neuradiab Further Validated by Independent Findings
3. Phase III Clinical Trial with 4-Month Long-Acting Formulation of Triptorelin: Ipsen Decides Not to Perform Further Administration
4. New Data on Market-Leading Velcade (Bortezomib) for Injection Further Strengthen Role in Previously Treated Multiple Myeloma
5. Liponex Inc. Reports Further Analysis of CRD5 Phase I/II Clinical Trial Data
6. MIV Therapeutics Announces Pivotal Test Results Further Validating Company Stent Coatings Meet Critical FDA Fatigue Guidelines
7. Neurologix Announces Publication of Landmark Gene Therapy Study Demonstrating Safety and Statistically Significant Improvement in Patients With Advanced Parkinsons Disease
8. Medivations Dimebon Maintains Statistically Significant Benefit on All Five Efficacy Endpoints in Alzheimers Disease Trial After One Year of Therapy
9. Repros Androxal Shows Highly Statistically Significant Positive Effects in Men with Secondary Hypogonadism
10. Positive Statistical Analysis from Synthetic Bloods Oxycyte Traumatic Brain Injury Trial Indicates Achievement of Primary Endpoint
11. ISTA Pharmaceuticals Announces Statistically Significant Preliminary Results From its U.S. Phase II/III Clinical Study Of Bepotastine

Post Your Comments:
(Date:11/6/2009)...-- Philips Respironics applauds the efforts of the...to raise awareness about an important public healt...release of the first-ever government study to moni... a milestone in quantifying the size and scope of ...try leader and sleep therapy manufacturer, Philips...
(Date:11/6/2009).../ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX...r 10, 2009 at 8:30 a.m. EST to discuss the third q... for the remainder of 2009. Ron Bentsur, Chief Ex.... Keryx will announce its financial results for t...o the call. ,, In order to participate in the c...
(Date:11/6/2009)... -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX) ...opharmaceutical company developing human vaccines ...cy Virus) and other infectious agents, today annou...provided an operational update. ,, Robert McNal...ommented, "We are pleased with our progress during...
Breaking Medicine Technology:Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 2Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST 2GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 2GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 4GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 5GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 6GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 7GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 8VIDEO from Medialink and the American Academy of Orthopaedic Surgeons 3A American Joint Replacement Registry Announced 52848 1VIDEO from Medialink and the American Academy of Orthopaedic Surgeons 3A American Joint Replacement Registry Announced 52848 2DURECT Corporation Invites You to Join Its Second Quarter 2009 Earnings Conference Call 52847 1DURECT Corporation Invites You to Join Its Second Quarter 2009 Earnings Conference Call 52847 2Watson CFO Mark W Durand to Take Leave of Absence 52845 1Watson CFO Mark W Durand to Take Leave of Absence 52845 2
... Thousands of,research studies have documented how... the cardiovascular system, particularly among peo...credible volume of research on this,topic creates ...y current,with findings and recommendations relate...ic Proceedings, contributors briefly,summarize cur...
...PARI,s LC STAR nebulizer and,PRONEB Ultra II compr...re,Pharmaceuticals, (Nasdaq: ISPH ) second Phase ...is treatment. PARI reusable nebulizers are,conside...recommended in,commercial sales including AstraZen...rovana, Novartis, TOBI, Genentech,s Pulmozyme, and...
Other Medicine Technology:Mayo Clinic Proceedings Contributors Highlight Research Findings About Cardiovascular Benefits Associated With Omega-3 Fatty Acids 2Mayo Clinic Proceedings Contributors Highlight Research Findings About Cardiovascular Benefits Associated With Omega-3 Fatty Acids 3PARI Nebulizer & Compressor Used Exclusively in Inspire's Phase 3 CF Trial 2
(Date:11/8/2009)...are Reform Bill ,, Critical legislation would...ricans ,, BALTIMORE, Nov. 7 /PRNewswire-USNews...e of Representatives passed critical health care r...or seniors and end discrimination by insurance com...fordable health coverage. ,, The Affordable Hea...
(Date:11/7/2009).../ -- The American Medical Association (AMA) today ...ip and Community Service to Manus C. Kraff, M.D., ...ognizes physicians who have gone above and beyond ...ding public service contribution to their local co... the opening session of the 2009 Interim Meeting o...
(Date:11/7/2009)... -- Members of the AMA are trying a last-minute ta...ng the AMA,s support of HR 3962. ,, "We want t...heir PATIENTS, not the leadership of the AMA," sai...iation of American Physicians and Surgeons, and Ta...ups. ,, "If the AMA leadership ignores the pub...
(Date:11/7/2009)...re/ -- Speaker Nancy Pelosi and Democratic leaders...g a Democratic Whip meeting with President Obama i... opening remarks: ,, "Thank you very much, Mr....eive the President of the United States on this da... making progress for the American people. ,, ...
(Date:11/7/2009)...cross the U.S. , , SATURDAY, Nov. 7 (Healt... colleges do it regularly (and, it,s not sex). , R... alcoholic drinks at a sitting. , "People have a h...y Hwang, associate dean of students and director o...on Long Island, N.Y. In fact, she said, heavy drin...
Breaking Medicine News(10 mins):Health News:AARP Maryland Key Vote News Alert 2Health News:AARP Maryland Key Vote News Alert 3Health News:AMA Honors IL Ophthalmologist Manus C. Kraff M.D. for Volunteer Eye Care for Military Members 2Health News:Pelosi Remarks Following House Democrats' Meeting with President Obama 2Health News:Binge Drinking Puts the Brain, and Life Itself, at Risk 2Health News:Binge Drinking Puts the Brain, and Life Itself, at Risk 3
...ON, Pa., March 5 Secretary of Health Dr.,Calvin B...at the Primary,Health Net Medical Clinic in Sharon...rell to discuss Governor Edward G. Rendell,s plan ...dable insurance is critical to help prevent diseas...
...w unit is designed to meet the needs of emerging l...tretchers -, FRANKLIN, Mass., March 5 Many of th...e healthcare market utilize components such,as fra...heir legs normally are too high to extend under th...
...EW YORK (March 5, 2008) -- Growing evidence shows ...-- an approach that not only may change the way th...y of thinking about diabetes. , A new article -- ...e small bowel as the possible site of critical mec...
...INGTON, March 5 The Tobacco-Free Kids,Action Fund...campaign,urging key Pennsylvania lawmakers to stop...that applies to all workplaces and protects all,Pe... of six key legislators with a warning to,readers ...
...Researchers now have a possible solution for the o...s as prescribed by their doctors, as well as for e...cklace that records the exact time and date when s...derly, but so is taking the medication at the wron...
...ARBOR, Mich., March 5 HealthMedia, the global,lea... outcomes, experienced,its highest earnings for an...ed by several new contracts, HealthMedia,s healthc...ue increased 88,percent in 2007, compared to 2006 ...
Other Medicine News:Health News:Pennsylvania Health Secretary Visits Mercer County to Call for Health Insurance for All Pennsylvanians 2Health News:Liko Introduces New LowBase(TM) Model of Its Popular Golvo Mobile Lift 2Health News:Type 2 diabetes may be caused by intestinal dysfunction 2Health News:Type 2 diabetes may be caused by intestinal dysfunction 3Health News:Type 2 diabetes may be caused by intestinal dysfunction 4Health News:Ad Campaign Urges Pennsylvania Lawmakers to Stop Waffling and Pass Comprehensive Smoke-Free Law 2Health News:Ad Campaign Urges Pennsylvania Lawmakers to Stop Waffling and Pass Comprehensive Smoke-Free Law 3Health News:Sensor necklace aims to increase elderly and clinical trial participant drug compliance 2Health News:Sensor necklace aims to increase elderly and clinical trial participant drug compliance 3Health News:Sensor necklace aims to increase elderly and clinical trial participant drug compliance 4Health News:HealthMedia Fourth Quarter 2007 Produces Highest Revenue in Company History 2
...he widest offering of single-use instruments on th...long 43cm lengths for Bariatric Surgery. , Dual a...sulation covers the pivot points to reduce the cha...cord, which eliminates gapping at connection and t...
MultAcoice™™ Rongeur Handle With Ratchet and Monopolar Cautery
MultAcoice™ 5 mm Insulated Outer Shaft
...order products are offered as 1-piece or modular, ...ruments may be customized with handles of choice a...flush ports. Many standard patterns are available ...ffect delivery times. , Please Note: Individual ...
Medicine Products: